Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 4 (2018) Approaches to therapy for depressions in neurology: prospects for the use of agomelatine Abstract  similar documents
D. V. Romanov, B. A. Volel, D. S. Petelin
"... of patients with post-stroke depression, Parkinson’s disease, Alzheimer’s disease, Pick’s disease, Huntington’s ..."
 
Vol 11, No 1 (2019) Antidepressant therapy in patients with cardiovascular diseases Abstract  similar documents
V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya
"... the high efficiency and good tolerability of agomelatine, an antidepressant with an innovative mechanism ..."
 
Vol 11, No 2 (2019) Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression Abstract  similar documents
L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova
"... Objective: to develop and justify differentiated indications for the use of agomelatine (valdoxan ..."
 
Vol 3, No 2 (2011) Role of melatonin in the treatment of depression Abstract  similar documents
O. V. Kotova
"... a wide range of drugs that are able to affect melatonin metabolism, amongst which there is agomelatine ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Mental disorders in Huntington’s disease Abstract  similar documents
S. A. Klyushnikov, E. N. Yudina, S. N. Illarioshkin, I. A. Ivanova-Smolenskaya
 
Vol 6, No 2 (2014) Predementia states and dementia in young people Abstract  similar documents
A.A. Smirnov, A.V. Gustov, S.V. Kopishinskaya, V.A. Antonova
"... in patients with neuroAIDS, Huntington’s disease, or multiple sclerosis. ..."
 
Vol 5, No 4 (2013) A case of Niemann – Pick disease type C Abstract  similar documents
Sergei Anatolyevich Klyushnikov, O R Smirnov, E Yu Zakharova
"... The paper describes a clinical case of a 27-year-old female patient with Niemann – Pick disease ..."
 
Vol 4, No 3 (2012) Efficacy of valdoxan in the prevention and treatment of post-stroke depression Abstract  similar documents
Dina Rustemovna Khasanova, Yu V Zhitkova, A A Safiullina
"... The efficacy of valdoxan (agomelatine) used to prevent and treat post-stroke depression ..."
 
Vol 8, No 3 (2016) A clinical case of adult onset Niemann–Pick disease type C Abstract  similar documents
E. V. Saifullina, R. V. Magzhanov, A. K. Mardanova, T. Yu. Proshlyakova, E. Yu. Zakharova, S. A. Klyushnikov, S. N. Illarioshkin
"... The paper presents a brief review of an update of the etiology and pathogenesis of Niemann–Pick ..."
 
Vol 11, No 4 (2019) Clinical and functional remission assessment in patients with recurrent depression Abstract  similar documents
N. N. Petrova
"... using agomelatine as an example. Conclusion. When assessing the results of treatment for depression ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... in the nigrostriatal system. Levodopa preparations and dopamine receptor agonists (DRAs) that are prescribed ..."
 
Vol 4, No 2 (2012) Sigma receptors: their role in the treatment of affective disorders  similar documents
V E Medvedev
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
Marina Romanovna Nodel
"... therapy with the dopamine receptor agonist pramipexole (Mirapex). Patients and methods ..."
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments Abstract  similar documents
I.S. Preobrazhenskaya
"... The paper discusses the possibilities of using the NMDA receptor antagonist memantine in patients ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... Dopamine (DA) receptor agonists ensure stimulation of DA receptors in the brain, by compensating ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... The efficacy of dopamine receptor agonists (DRAs) is determined by a number of advantages. DRAs ..."
 
Vol 10, No 2 (2018) Current management tactics for patients with dementia Abstract  similar documents
A. V. Medvedeva, O. V. Kosivtsova, K. A. Makhinov
"... inhibitors and N-methyl-D-aspartate (NMDA) glutamate receptor antagonists. Atypical neuroleptics are employed ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease at a young age Abstract  similar documents
D. V. Artemyev
"... . Emphasis is laid on the key role of non-ergoline dopamine receptor agonists in the treatment of patients ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive and neuropsychiatric disorders in extrapyramidal diseases Abstract  similar documents
O. S. Levin, M. A. Anikin, E. E. Vasenina
"... of Parkinson’s disease or Huntington’s disease in persons who are predisposed to these diseases. Moreover ..."
 
Vol 4, No 1 (2012) Association of the dopamine receptor (DRD4, DAT) gene polymorphisms with vital exhaustion in an open population among 25—64-year-old men (Novosibirsk): Epidemiological study according to the WHO MONICA-psychosocial program Abstract  similar documents
Valery Vasilyevich Gafarov, M I Voyevoda, E A Gromova, V N Maksimov, A V Gafarova, I V Gagulin, N S Yudin, T M Mishakova
"... of Medical Sciences (Novosibirsk). Results. The genotype containing allele 7 in the dopamine receptor subtype ..."
 
Vol 8, No 2 (2016) Alzheimer's disease under the mask of stroke Abstract  similar documents
A. A. Naumenko, N. V. Vakhnina
"... and vascular CIs are acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists ..."
 
Vol 8, No 4 (2016) ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT Abstract  similar documents
A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya
 
Vol 10, No 4 (2018) Cognitive and motor training for patients with moderate cognitive impairment and mild dementia Abstract  similar documents
A. A. Naumenko, I. S. Preobrazhenskaya
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Non-drug therapies for cognitive impairment Abstract  similar documents
I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova
 
Vol 9, No 2 (2017) Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova
"... that thiamine disulfide can inhibit the molecular receptors involved in blood pressure regulation: adrenoceptors ..."
 
Vol 10, No 2 (2018) Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov
"... and discussion. GS interacts with the receptors CD44, TLR4, and ICAM1 on the surface of chondrocytes, inhibits ..."
 
Vol 4, No 1 (2012) Antyhypertensive therapy-based secondary prevention of ischemic stroke Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya, Yu A Starchina
"... ischemic attack. The possible neuroprotective effects of angiotensin II receptor blockers are discussed ..."
 
Vol 5, No 4 (2013) Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
"... to the pathogenetic therapy for dementia and the efficiency and safety of using NMDA receptor antagonists in patients ..."
 
Vol 5, No 1 (2013) Blood pressure lowering-based prevention and the POWER trial Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... results of the POWER trial evaluating the safety and efficacy of eprosartan, an angiotensin receptor ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Management of patients with post-stroke dementia Abstract  similar documents
Svetlana Viktorovna Verbitskaya
"... the efficacy of central acetylcholinesterase inhibitors and the NMDA receptor antagonist akatinol memantine ..."
 
Vol 8, No 3 (2016) Systematic analysis of basic and clinical studies of etifoxine Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, V. A. Semenov, T. R. Grishina
"... . The anxiolytic effect of etifoxine is due, firstly, to the modulation of GABA receptor activity and, secondly ..."
 
Vol 8, No 4 (2016) NEUROTROPHIC EFFECTS OF ETIFOXINE Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, V. A. Semenov, O. A. Limanova, I. V. Gogoleva
"... ; these are to relieve allodynia related to 3α-steroids and GABA receptors and to effectively treat cerebral edema ..."
 
Vol 10, No 1 (2018) Cranial dystonia Abstract  similar documents
V. A. Tolmacheva
"... and from the receptors within it. Botulinum toxin preparations show the highest efficacy in treating ..."
 
Vol 8, No 3 (2016) Chemoreactome analysis of ethylmethylhydroxypyridine succinate Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov
"... of acetylcholine and GABA receptors, as well as that of cannabinoid receptor type 2. The anti-inflammatory effect ..."
 
Vol 8, No 2 (2016) Effects of etifoxine: Chemoreactome simulation Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov
"... neurotransmitter receptors; 2) anti-inflammatory activity; 3) the effect on hemodynamics and vascular walls; 4 ..."
 
Vol 10, No 1 (2018) Vascular myelopathy: causes and mechanisms, possibilities of diagnosis and treatment Abstract  similar documents
G. V. Ponomarev, A. A. Skoromets, V. S. Krasnov, O. V. Rodionova, D. D. Glistenkova, N. F. Porkhun, S. A. Dambinova
"... stages. The investigation and introduction of specific biochemical markers (glutamate receptors ..."
 
Vol 11, No 1 (2019) Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. M. Lila, N. A. Shostak, K. V. Rudakov
"... with CD44 receptor, the CS/GS molecules inactivate the proinflammatory factor NF-kB, the activity of which ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... ) receptor; SLC1A2 encoding the glial glutamate transporter; and GRIK4 encoding the ionotropic glutamate ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ The role of neuroinflammation in the pathogenesis of epilepsy Abstract  similar documents
L. V. Lipatova, N. B. Serebryanaya, N. A. Sivakova
"... ), IL-1 receptor  antagonist (IL-1RA), soluble IL-2 receptor (sIL-2R), brain- derived neurotrophic ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease Abstract  similar documents
I. G. Tishkova, I. S. Preobrazhenskaya
"... probably caused by the hypersensitivity of denervated receptors to humoral factors. As the denervation ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... or hypersexuality, the dose of dopaminergic receptor agonists was gradually reduced and subsequently discontinued. ..."
 
Vol 11, No 3 (2019) he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments Abstract  similar documents
I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova, K. M. Naumov, I. A. Lupanov, G. A. Kilivaeva, M. R. Alizade
"... (Akatinol memantine, an inhibitor of NMDA receptors and glutamatergic excitotoxicity) for the treatment ..."
 
Vol 11, No 4 (2019) New possibilities for the therapy of secondary progressive multiple sclerosis Abstract  similar documents
A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov
"... sphingosine-1-phosphate types 1 and 5 receptor modulator that has been shown to be more effective than placebo ..."
 
Vol 11, No 4 (2019) Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» Abstract  similar documents
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
"... with the advent of siponimod, a new molecular class of S1P receptor modulators. The confirmed efficiency ..."
 
Vol 7, No 4 (2015) Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations Abstract  similar documents
A. N. Belova, D. N. Shakurova, E. V. Gayazova
"... of a review of the Russian and foreign literature. Naftidrofuryl is a seroton 5-HT2 receptor antagonist ..."
 
Vol 6, No 1S (2014): Special issue "Epilepsy" Genetics of Epilepsy: What for and How to Examine Children with Epilepsy E.D. Belousova Abstract  similar documents
E. D. Belousova
"... the alpha subunit of NMDA receptors was muted in 17.6% of children with this syndrome. The need ..."
 
Vol 9, No 1 (2017) The triple synergy of ethylmethylhydroxypyridine succinate, magnesium, and vitamin B6: Molecular mechanisms Abstract  similar documents
O. A. Gromova, A. G. Kalacheva, I. Yu. Torshin, T. R. Grishina, I. K. Tomilova
"... and neuromuscular transmission, to reduce anxiety, by activating acetylcholine, GABA, and dopamine receptors ..."
 
Vol 10, No 1 (2018) Comparative chemoreactome analysis of dexketoprofen, ketoprofen, and diclofenac Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L E. Fedotova, A. N. Gromov
"... that of leukotrienes and encephalins, as well as via inhibition of metalloproteinases and glutamate receptors ..."
 
Vol 7, No 1 (2015) Current therapy for chronic cerebrovascular attack Abstract  similar documents
A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova
"... , donepezil) and a reversible NMDA receptor blocker (memantine) are symptomatically used at a stage ..."
 
Vol 9, No 4 (2017) Sleep disorders in Parkinson’s disease: approaches to treatment and prevention Abstract  similar documents
M. R. Nodel, G. V. Kovrov
"... therapy with long- acting ropinirole, a D2-receptor agonist. Approaches to the pharmacotherapy of non ..."
 
Vol 6, No 1 (2014) Severe dementia: diagnosis, patient management, prevention of complications Abstract  similar documents
A.B. Lokshina
"... dementia with acetylcholinesterase inhibitors and/or a competitive blocker of the NMDA-receptor, memantine ..."
 
Vol 10, No 4 (2018) Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease Abstract  similar documents
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno
"... with levodopa at a mean daily dose of 667.8 mg; 98 of them had the drug in combination with dopamine receptor ..."
 
Vol 11, No 2 (2019) Comparative study of pharmacological correction strategies for moderate cognitive impairment in hypertensive patients Abstract  similar documents
O. V. Vorobyeva, Zh. M. Sizova, L. M. Bogatyreva
"... receptor agonist piribedil. Patients and methods. At the first stage of the investigation, the prevalence ..."
 
Vol 11, No 2 (2019) Effciency of a rehabilitation training method by means of special infant formulas in patients with ischemic stroke and neurogenic dysphagia as part of combined therapy Abstract  similar documents
V. I. Ershov, A. A. Belkin, A. V. Karpets, S. V. Zdvizhkova, A. P. Gonchar-Zaikin, N. V. Gumalatova
"... receptor apparatus; the most active restoration of a dynamic swallowing stereotype occurs. The gradual ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
 
1 - 57 of 57 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)